Interventions for valvular disease How should I treat a patient with a mechanical aortic valve prosthesis and recurrent intracranial bleeding on anticoagulation with a patent LIMA to LAD? Patterson T, Davies W, Rajani R, Redwood S, Young C, Thomas M, Bosmans J, Rodrigus I, Melnitchouk S, Sundt T June 20, 2016 | 10.4244/EIJV12I3A69
The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis Khawaja M, Asrress K, Haran H, Arri S, Nadra I, Bolter K, Wilson K, Clack L, Hancock J, Young C, Bapat V, Thomas M, Redwood S August 20, 2015 | 10.4244/EIJY14M05_09
Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches Bona V, Khawaja M, Bapat V, Young C, Hancock J, Redwood S, Fusari M, Thomas M June 19, 2015 | 10.4244/EIJV11I2A41
Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M September 27, 2014 | 10.4244/EIJV10SUA18
Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty Davies W, Bapat V, Hancock J, Young C, Redwood S, Thomas M June 20, 2014 | 10.4244/EIJV10I2A40
The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis Khawaja M, Thomas M, Joshi A, Asrress K, Wilson K, Bolter K, Young C, Hancock J, Bapat V, Redwood S September 28, 2012 | 10.4244/EIJV8I5A87
Complications of transcatheter aortic valve implantation: avoidance and management Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, Maccarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N September 30, 2011 | 10.4244/EIJV7I5A99
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019